Last reviewed · How we verify
NCT02970799
Tear Production by Nasal Neurostimulation Compared to Active Control
NA trial testing Intranasal Neurostimulator in Dry Eye in 27 participants. Completed in 31 October 2016.
31 October 2016
Quick facts
| Lead sponsor | Oculeve, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 27 |
| Start date | 31 August 2016 |
| Primary completion | 31 October 2016 |
| Estimated completion | 31 October 2016 |
Drugs / interventions tested
- Intranasal Neurostimulator
Conditions studied
- Dry Eye — all drugs for Dry Eye →
- Dry Eye Syndromes — all drugs for Dry Eye Syndromes →
- Keratoconjunctivitis Sicca — all drugs for Keratoconjunctivitis Sicca →
Sponsor
Oculeve, Inc.
Who can join
22 and older, any sex, with Dry Eye or Dry Eye Syndromes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This crossover design study evaluates the effectiveness of the Oculeve Intranasal Neurostimulator comparing the effect of intranasal (active) versus extranasal (control) stimulation on tear production as measured by the Jones Schirmer test in participants with dry eye disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02970799
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dry Eye
Currently open trials in the same condition.
- NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
- NCT07329712 — Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low Level Light Therapy · recruiting
- NCT07266948 — Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work · Phase 4 · recruiting
- NCT07298811 — Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment · Phase 1, PHASE2 · recruiting
- NCT07135193 — Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Ath · NA · active not recruiting
Other Oculeve, Inc. trials
Trials by the same sponsor.
- NCT03097614 — Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment · NA · completed
- NCT02680158 — A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry · NA · completed
- NCT02526290 — Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator · NA · completed
- NCT02385292 — Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02970799 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oculeve, Inc.
- Last refreshed: 19 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02970799.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing